Discover the full insider trade history of 삼익제약, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €128.1bn. The latest transaction was disclosed on 26 March 2026 — Purchase. Among the most active insiders: 권영이. Every trade is openly available.